Skip to main content
. Author manuscript; available in PMC: 2023 Aug 1.
Published in final edited form as: Neurogastroenterol Motil. 2022 Feb 3;34(8):e14326. doi: 10.1111/nmo.14326

Table 2.

Gastric, Small Bowel, and Colonic Transit in 166 Patients with MS (n refers to number with available data)

Parameters Normal values Total group Phase of MS
Relapsing-remitting Progressive P# value
n Median, IQR n Median, IQR n Median, IQR
GE 1h, % 4.4–35.0 110 26.5 (18.0, 37.0) 75 25.0 (18.0, 35.0) 35 30.0 (18.0, 42.0) 0.38
GE 2h, % 25.0–78.5 165 54.0 (34.5, 67.5) 110 53.0 (34.0, 63.5) 67 59.5 (43.7, 76.2) 0.73
GE 4h, % 76.2–100 163 92.0 (81.0, 97.0) 110 92.0 (80.0.3, 97.0) 55 92.0 (82.0, 97.0) 0.84
CF 6h, % 0–100 116 66.5 (38.0, 81.8) 72 65.0 (38.0, 80.8) 44 67.0 (33.5, 83.5) 0.41
GC 24h 1.47–3.86 81 1.9 (1.4, 2.7) 51 2.0 (1.4, 2.8) 30 1.8 (1.5, 2.4) 0.84
GC 48h 2.1–5.0 8 2.7 (2.0, 3.7) 5 3.1 (2.0, 3.7) 3 2.3 (1.6, 3.9) 0.65
#

Group comparison of progressive and relapsing-remitting MS using two-sample t-test for GE and CF, and Wilcoxon rank sum test for GC.

GE=gastric emptying; GC=geometric center; CF=colonic filling at 6 hours is a surrogate for small bowel transit; normal values are from references 12 and 15.